Cencora(COR) - 2022 Q4 - Earnings Call Presentation

Financial Performance - Q4 FY2022 - Revenue remained consistent year-over-year at $61.2 billion, reflecting a 3.8% increase[6] - Gross profit decreased by 4.1% to $2.0 billion on a GAAP basis, but increased by 4.8% to $2.1 billion on an adjusted (non-GAAP) basis[6] - Operating income decreased by 19.1% to $455 million (GAAP) but increased by 6.8% to $741 million (Adjusted)[6] - Net income attributable to AmerisourceBergen decreased by 32.7% to $295 million (GAAP) but increased by 8.4% to $546 million (Adjusted)[6] - Diluted earnings per share decreased by 32.7% to $1.40 (GAAP) but increased by 8.8% to $2.60 (Adjusted)[6] Financial Performance - FY2022 - Revenue increased by 11.5% year-over-year to $238.6 billion[7] - Gross profit increased by 19.5% to $8.3 billion (GAAP) and 27.9% to $8.4 billion (Adjusted)[7] - Operating income increased by 0.5% to $2.4 billion (GAAP) and 19.5% to $3.2 billion (Adjusted)[7] - Net income attributable to AmerisourceBergen increased by 10.3% to $1.7 billion (GAAP) and 20.7% to $2.3 billion (Adjusted)[7] - Diluted earnings per share increased by 8.8% to $8.04 (GAAP) and 19.1% to $11.03 (Adjusted)[7] FY2023 Guidance (Consolidated) - Revenue is projected to increase by 5% to 7% as reported, or 6% to 8% on a constant currency basis[14] - Adjusted operating income is expected to increase by 0% to 3% as reported, or 3% to 6% on a constant currency basis, and 3% to 5% excluding COVID-19 contributions, or 6% to 8% on a constant currency basis excluding COVID-19[14] - Adjusted diluted earnings per share are projected to be between $11.30 and $11.60, representing growth of 2% to 5% as reported, or 4% to 7% on a constant currency basis, and 7% to 9% excluding COVID-19 contributions, or 9% to 11% on a constant currency basis excluding COVID-19[14] - Adjusted free cash flow is estimated to be approximately $2 billion[14]